Epazz DeskFlex Metaverse Solution Takes Telemedicine in Augmented Reality Environment for Accurate Patient Assessment and Diagnosis

Chicago, Illinois–(Newsfile Corp. – February 10, 2022) – Epazz Inc. (OTC Pink: EPAZ), a mission-critical provider of metaverse solutions, blockchain cryptocurrency mobile apps, and cloud-based business software solutions, announced today that the DeskFlex Metaverse Business Solutions help doctors diagnose patients’ illnesses via Telemedicine augmented reality using Epazz Slims.

The Epazz Slims are virtual reality glasses embedded with multiple nano cameras and motion sensors to help create an actual 3D representation of people. It will complement DeskFlex Metaverse Virtual Telemedicine technology and will be significantly more affordable than what is currently available on the market.

The Metaverse technology will allow patients and physicians to meet virtually and converse in real-time during the clinical assessment, with total sensory involvement. The patient will be able to feel a sense of touch, and general movement in augmented reality.

It will be an avenue to communicate the actual ailing body part in 3D representation with your doctor. The Epazz Slims integrated cameras will create the 3D avatar of the patient, and real-time interactions and discussions are possible.

The Epazz DeskFlex Metaverse Telemedicine technology is beneficial to far-flung patients to get treated by the best doctors and health specialists through the Epazz DeskFlex Metaverse Telemedicine technology.

Epazz-DeskFlex will soon be adding software and hardware components to launch the DeskFlex Metaverse Virtual Telemedicine technology. The solution will be launching this year.

Epazz, Inc,’s Chairman and CEO Dr. Shaun Passley commented: “We witnessed the struggles of patients getting treated by health specialists during the pandemic. So, we further advanced the DeskFlex room booking technology to deliver quality medical services through augmented reality Telemedicine, for accurate diagnosis and comprehensive patient assessment.”

About Epazz Inc. (http://www.epazz.com/)

Epazz Inc. is a mission-critical provider of metaverse solutions, blockchain, cryptocurrency mobile apps, a cloud-based software company specializing in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz is developing Metaverse business solutions that enable people to collaborate in real-time through virtual reality. Epazz is upgrading its business solutions to integrate into the Metaverse fully. Epazz will be manufacturing low-cost smart glasses for Metaverse.

SAFE HARBOR

The “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of forward-looking languages, such as “may”; “expect”; “intend”; “estimate”; “anticipate”; “believe”; “continue”; the negative thereof or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause the actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance, and actual results may differ materially from those contemplated by such forward-looking statements. Epazz Inc. assumes no obligation and has no intention of updating forward-looking statements. It has no obligation to update or correct information prepared by third parties that are not paid for by Epazz Inc. Investors are encouraged to review Epazz Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC Markets filings, which contain general business information about the results of its operations, and risks associated with the company and its operations.

Contact
For more information, please contact
Investor Relations
investors@epazz.net
312-955-8161
www.epazz.com

To view the source version of this press release, please visit http://www.newsfilecorp.com/release/113382

Previous post 21Shares Announces the Listing of Decentraland and FTX Token on BX Swiss
Next post MvPad (MVD) is Now Available for Trading on LBank Exchange
Exit mobile version